• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Digestive Remedies in the US Product Image

Digestive Remedies in the US

  • Published: April 2013
  • 50 pages
  • Euromonitor International

2012 was another turbulent year for digestive remedies. McNeil’s ongoing manufacturing quality issues led to unpredictable or non-existent availability of such popular heartburn and indigestion brands as Pepcid, Mylanta and Rolaids, as well as previously dominant paediatric indigestion brand Mylicon. In addition, the company was compelled to initiate another recall of Imodium AD diarrhoeal remedies in May 2012 due to a packaging issue. Meanwhile, Novartis struggled with production failures of...

Euromonitor International's Digestive Remedies in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.

Product coverage: Diarrhoeal Remedies, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Motion Sickness Remedies, Paediatric Digestive Remedies.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
- Get a detailed picture of the Digestive Remedies market;
- READ MORE >

DIGESTIVE REMEDIES IN THE US
Euromonitor International
April 2013

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Digestive Remedies by Category: Value 2007-2012
Table 2 Sales of Digestive Remedies by Category: % Value Growth 2007-2012
Table 3 Digestive Remedies Company Shares by Value 2008-2012
Table 4 Digestive Remedies Brand Shares by Value 2009-2012
Table 5 Forecast Sales of Digestive Remedies by Category: Value 2012-2017
Table 6 Forecast Sales of Digestive Remedies by Category: % Value Growth 2012-2017
Bayer Corp in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 1 Bayer Corp: Key Facts
Company Background
Production
Competitive Positioning
Summary 2 Bayer Corp: Competitive Position 2012
Cvs Caremark Corp in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 3 CVS Caremark Corp: Key Facts
Summary 4 CVS Caremark Corp: Operational Indicators (Retail Pharmacy Segment)
Company Background
Production
Competitive Positioning
Summary 5 CVS Caremark Corp: Competitive Position 2012
Mcneil Consumer & Specialty Pharmaceuticals in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 6 McNeil Consumer & Specialty Pharmaceuticals: Key Facts
Summary 7 McNeil Consumer & Specialty Pharmaceuticals: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 8 McNeil Consumer & Specialty Pharmaceuticals: Competitive Position 2012
Pfizer Consumer Healthcare Inc in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 9 Pfizer Consumer Healthcare Inc: Key Facts
Summary 10 Pfizer Consumer Healthcare Inc: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 11 Pfizer Consumer Healthcare Inc: Competitive Position 2012
Walgreen Co in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 12 Walgreen Co: Key Facts
Summary 13 Walgreen Co: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 14 Walgreen Co: Competitive Position 2012
Wal-mart Stores Inc in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 15 Wal-Mart Stores Inc: Key Facts
Summary 16 Wal-Mart Stores Inc: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 17 Wal-Mart Stores Inc: Competitive Position 2012
Executive Summary
Consumer Health Continues Its Upward Climb
Manufacturing Issues Worsen Rather Than Improve
Private Label Producers Capitalise on Branded Product Challenges
Retailers Aim To Play A Broader Role in Consumers' Lives
OTC Rebound Will Drive Higher Growth Over the Forecast Period
Key Trends and Developments
Continuing the Balance Between Industry and Government
Baby Boomers Impact on Vitamins and Dietary Supplements
Growth in Protein Is Bulking Up in Strength
Manufacturing Issues Continue To Plague Consumer Health
Regulatory Prospects Alter Strategic Landscape
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services 2007-2012
Table 8 Life Expectancy at Birth 2007-2012
Market Data
Table 9 Sales of Consumer Health by Category: Value 2007-2012
Table 10 Sales of Consumer Health by Category: % Value Growth 2007-2012
Table 11 Consumer Health Company Shares 2008-2012
Table 12 Consumer Health Brand Shares 2009-2012
Table 13 Penetration of Private Label by Category 2007-2012
Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
Table 16 Forecast Sales of Consumer Health by Category: Value 2012-2017
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 18 OTC: Switches 2010-2012
Sources
Summary 19 Research Sources

Format Properties
Electronic (PDF) The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.
Site License The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.
Enterprisewide The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.
Note: Product cover images may vary from those shown
More

RELATED PRODUCTS

Our Clients

Our clients' logos